Oyster Point Pharma, Inc. (OYST) [Rocket]

In millions, except per share items	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21	Dec-31-20
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Net income	-36.7	-49.9	-47.9	-42.1	-17.7	-22.0	-18.9	-22.2
Depreciation and amortization	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
Asset impairment charges	0.0	-0.1
Stock-based compensation	3.8	4.2	4.4	3.1	3.1	3.0	2.7	2.2
Change in working capital [+]	-3.7	2.5	-10.1	-4.4	3.9	-1.6	-0.3	-1.0
Accounts receivable	-2.3	-5.2	0.9	-6.7
Inventories	-0.9	-4.3	-0.4	-7.0
Other current assets	1.5	3.9	-5.0	-6.1	0.7	2.7	-2.9	-2.6
Accounts payable	-0.6	2.2	-3.9	2.7	1.2	-4.8	4.8	0.0
Accrued expenses	-1.4	5.9	-1.7	10.1	4.6	0.5	-2.2	1.5
Other			0.0	2.5	-2.5
Other operating activities	0.6	4.4	3.9	1.8	-0.2	0.0	0.0
Cash from operations	-36.0	-38.8	-49.7	-41.5	-10.8	-20.6	-16.5	-21.1

Capital expenditures	0.0	-0.1	-0.1	-0.2	-0.3	-0.7	-0.3	-0.4
Purchases of property and equipment		-0.1	-0.1	-0.2	-0.3	-0.7	-0.3	-0.4
Cash from investing	0.0	-0.1	-0.1	-0.2	-0.3	-0.7	-0.3	-0.4

Issuance of common stock, net				95.0
Option exercises	0.0	0.5	0.1	1.0	0.3	0.1	0.2	0.0
Financing costs				-4.9
Other cash from financing	-0.2	1.0	-0.1	-48.0	40.7	0.2	0.4	-0.3
Cash from financing	-0.2	0.5	-0.2	50.9	40.4	0.1	0.2	-0.3

Free cash flow	-36.0	-38.9	-49.8	-41.7	-11.1	-21.2	-16.9	-21.4
Per share (diluted)	($1.34)	($1.46)	($1.87)	($1.60)	($0.42)	($0.82)	($0.65)	($0.89)

Cash paid for interest	2.4	2.1	2.1	1.7	0.6